Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Real Regulatory News (ARTL)

  • There is currently no data for ARTL

Share Buyback Programme

22 Jan 2021 16:22

RNS Number : 6619M
Alpha Real Trust Limited
22 January 2021
 

22 January 2021

LEI: 213800BMY95CP6CYXK69

 

ALPHA REAL TRUST LIMITED ("ALPHA REAL TRUST" OR THE "COMPANY")

Share Buyback Programme

Alpha Real Trust announces its intention to buy back its ordinary shares ("Share Repurchases") using its existing cash resources, pursuant to the general authority given to it at the Company's Annual General Meeting held on 7 August 2020 to make Share Repurchases of up to 8,979,021 ordinary shares (representing a maximum of 14.99 per cent. of the voting share capital of the Company).

The Share Repurchases have the sole purpose of reducing the issued ordinary share capital of the Company. As ordinary shares will not be acquired above the prevailing net asset value per share as reported on a quarterly basis, it is also expected to enhance its net asset value per ordinary share.

The programme will commence with effect from today and Share Repurchases may be undertaken until the earlier of the maximum amount being repurchased and the annual general meeting of the Company in 2021. The maximum amount of money allocated for the programme is £8 million.

Pursuant to, and during the term of, the Share Repurchases, the Company may purchase Ordinary Shares provided that:

1) the maximum price payable for an ordinary share on the Exchange shall not exceed:

a. the price which is 105 per cent. of the average market value of the Company's ordinary shares as derived from the London Stock Exchange Daily Official List for the five business days immediately preceding the day on which such ordinary share is contracted to be purchased; and

b. the price which is the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out; and

2) the aggregate number of ordinary shares which may be acquired on behalf of the Company in connection with the Share Repurchases shall not exceed 8,979,021 ordinary shares.

Due to the limited liquidity in trading of the Company's ordinary shares, Share Repurchases on any trading day are likely to represent a significant proportion of the daily trading volume in the ordinary shares (and are likely to exceed the 25% threshold of the average daily trading volume in both the month preceding this announcement and the 20 trading days preceding the date of the purchase as is set out in the Commission Delegated Regulation (EU) 2016/1052 and, as such, the Company would be deviating from the safe harbour set out in Article 5(1) of the Market Abuse Regulation (Regulation 596/2014)).

The Company will make further announcements in due course following the completion of any Share Repurchases. To the extent permitted by law, ordinary shares bought back under the Share Repurchases will be held as treasury shares or cancelled.

 

For further information please contact:

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust +44 (0) 20 7391 4700

Panmure Gordon, Broker to the Company

Atholl Tweedie / Joanna Langley +44 (0) 20 7886 2500

 

Alpha Real Trust Limited is advised by Alpha Real Capital LLP, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDKBBBABKDKDB
Date   Source Headline
22nd Jan 20252:35 pmRNSTransaction in Own Shares
21st Jan 20252:35 pmRNSShare Buyback
20th Jan 20254:28 pmRNSAcquisition of Crematoria
20th Jan 202510:06 amRNSResult of Tender Offer
20th Dec 202410:18 amRNSResult of Extraordinary General Meeting
17th Dec 20241:53 pmRNSAcquisition of Travelodge hotel in Liverpool, UK
13th Dec 202410:07 amRNSHalf-year Report 2024
6th Dec 20247:00 amRNSDelisting, Tender Offer, New Arts & Notice of EGM
22nd Nov 20247:00 amRNSHalf-year Report
1st Nov 20247:00 amRNSTotal Voting Rights
30th Oct 202411:04 amRNSDirector/PDMR Shareholding
29th Oct 202412:36 pmRNSDirector/PDMR Shareholding
29th Oct 202412:33 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSResults of Scrip Dividend Alternative Election
13th Sep 20247:00 amRNSTrading Update and Dividend Announcement
5th Sep 20241:31 pmRNSResult of AGM
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:10 pmRNSDirector/PDMR Shareholding
30th Jul 20243:09 pmRNSDirector/PDMR Shareholding
30th Jul 20243:08 pmRNSDirector/PDMR Shareholding
30th Jul 20242:27 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:00 amRNSResults of Scrip Dividend Alternative Election
5th Jul 20249:57 amRNSAnnual Financial Report and Financial Statements
21st Jun 20247:00 amRNSAnnual Results for the year ended 31.03.24
1st May 20247:00 amRNSTotal Voting Rights
19th Apr 20242:34 pmRNSDirector/PDMR Shareholding
18th Apr 202411:16 amRNSDirector/PDMR Shareholding
16th Apr 202412:35 pmRNSDirector/PDMR Shareholding
16th Apr 202412:33 pmRNSDirector/PDMR Shareholding
16th Apr 202412:32 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSResults of Scrip Dividend Alternative Election
8th Mar 20248:52 amRNSSale of H20 Shopping Centre Investment, Madrid
1st Mar 20247:00 amRNSTrading Update and Dividend Announcement
13th Feb 20245:03 pmRNSDirector/PDMR Shareholding
1st Feb 202411:58 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:08 amRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSResults of Scrip Dividend Alternative Election
15th Dec 20231:30 pmRNSHalf-year Report
6th Dec 20232:47 pmRNSDirector/PDMR Shareholding
27th Nov 20231:16 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20236:00 pmRNSDirector/PDMR Shareholding
31st Oct 20235:55 pmRNSDirector/PDMR Shareholding
31st Oct 20235:52 pmRNSDirector/PDMR Shareholding
25th Oct 20239:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.